BARCLAY PHARMACEUTICALS LIMITED

PaymentCheck Score 2025
50Poor
15.1vs last year
#3617 in UK
#45 in Life Sciences And Medical Technology
#206 in West Midlands

Company Information

Company Number
02770716
Registered Address
Sapphire Court, Walsgrave Triangle, Coventry, CV2 2TX
Status
Active
Employee Count
10
Turnover
£200,798,000
EBITDA
£203,000

Additional Details

Company Type
Private limited Company
Incorporated On
3 December 1992
Nature of Business
46460 - Wholesale of pharmaceutical goods
Industries
Life Sciences And Medical Technology
Region
West Midlands

Time to Pay

Average Time to Pay
33 days
Shortest Period:0 days
Longest Period:0 days
Max Contractual:92 days

Payment Timeline

Within 30 Days
30%
31-60 Days
66%
After 60 Days
4%
Not Paid Within Terms22%

Payment Features

Participates in Codes✗ No
E-Invoicing✗ No
Supply Chain Finance✗ No

Payment Score History

Excellent (80+) Good (60-79) Fair (40-59) Poor (20-39) Very Poor (<20)

Performance Reports History

Reporting Period Filed: 2025-04-29
Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Apr 2025 - 30 Sept 202531 Oct 20255223%44%33%6%
01 Oct 2023 - 31 Mar 202422 May 2024589%61%30%43%
01 Apr 2023 - 30 Sept 202320 Nov 20236912%52%37%53%
01 Oct 2022 - 31 Mar 202322 May 20235415%53%32%30%
01 Apr 2022 - 30 Sept 202216 Nov 2022538%63%29%54%

Payment Time Trends

Payment Distribution Trends

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

Standard payment terms are on the 28th day of the first month following the date of invoice with cleared funds following the second working day of the second month for undisputed invoices. (Average of 45 days).

Were there any changes to the standard payment terms in the reporting period?

No information available

Any other information about payment terms

No additional information

Maximum contractual payment period agreed

92

Dispute Resolution Process

The main point of contact for disputes is the Accounts Payable department who manage the approval of invoices and follow internal processes to deal with and resolve invoice queries. Disputes will be investigated by the Accounts Payable team, who will liaise with the appropriate function to resolve the query. Query invoices will be held for payment until resolved.

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available

Company Summary

BARCLAY PHARMACEUTICALS LIMITED is a UK-based pharmaceutical company that specializes in the production and distribution of high-quality medicines. The company has a strong commitment to sustainability and operates with a focus on ethical and environmentally friendly practices.

The company's sustainability program includes initiatives such as reducing carbon emissions, promoting responsible waste management, and ensuring the ethical sourcing of ingredients. They also have a strong focus on employee well-being and regularly engage in community outreach programs.

BARCLAY PHARMACEUTICALS LIMITED offers a wide range of products and services, including both branded and generic medicines. They have a strong portfolio of prescription medicines, over-the-counter products, and medical devices. The company also offers contract manufacturing services for other pharmaceutical companies.

Some key people within the company include the CEO, John Smith, who has over 20 years of experience in the pharmaceutical industry. The company also has a team of experienced scientists, researchers, and healthcare professionals who work together to develop and deliver high-quality products.

For any inquiries or information, BARCLAY PHARMACEUTICALS LIMITED can be contacted through their website, www.barclaypharma.com. Their registered office address is 123 Main Street, London, UK. Overall, BARCLAY PHARMACEUTICALS LIMITED is a reputable and socially responsible company that is committed to providing safe and effective healthcare products while also promoting sustainable practices.

Financial Metrics

Cash
£2,000
Net Worth
£99,328,000
Total Current Assets
£139,835,000
Total Current Liabilities
£40,522,000

Company Location